Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas

Thomas Hope

Overview

This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.

No health outcome measures will be obtained under this protocol.

Study Type

EXPANDED_ACCESS

Conditions

Parathyroid Adenomas

Interventions

18F-Fluorocholine (FCH)DRUG

A dose of 4-7 millicurie (mCi) +/- 10% of radiotracer 18F-Fluorocholine (FCH) manufactured at UCSF will be given intravenously.

Positron emission tomography (PET)PROCEDURE

A scan is a procedure that produces images of organs and tissues used in conjunction with a radiotracer.

Eligibility

Sex: ALLMin age: 13 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Age ≥ 13 years. 2. Evidence of primary hyperparathyroidism. 3. Ability to understand a written informed consent document, and the willingness to sign it. Exclusion Criteria: 1\. Unlikely to comply with protocol procedures, restrictions and requirements and judged by the Investigator to be unsuitable for participation.

Central Contacts

Maya Aslam

CONTACT

(415)514-8987 maya.aslam@ucsf.edu

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.